Share

The Devil Is in the [Vitamin] D-etails

Each year, the hottest tickets at ENDO are the various debates and ENDO 2023 was no exception when experts weighed in on the pros and cons of using vitamin D supplements in female patients at risk for osteoporotic fracture. One ENDO 2023 session that proved popular in June was “Is there a role for vitamin...
Share

Breaking Barriers in Bone Health

With the recent reexamination of how to consider race/ethnicity in medical treatment, many practitioners may feel confused about implementing such procedures. The ENDO 2023 symposium “Addressing Racial and Ethnic Disparities in Osteoporosis Care” provided attendees with an understanding of the impact of incorporating race/ethnicity in osteoporosis care as well as suggestions for treating their own...
Share

Topline Results Announced from Trial of Non-Pharmacological Treatment for Osteopenia

Bone Health Technologies (BHT) announced yesterday topline results of its pivotal trial of the Osteoboost Vibration Belt. The results found that using Osteoboost more than three times per week in each of four quarters provided a statistically significant reduction in the loss of vertebral bone strength among participants— with no reported device-related serious adverse events....
Share

Progression of Acromegalic Arthropathy Observed in Long-Term Study

Radiographic arthropathy progresses significantly in patients with long-term, well-controlled acromegaly, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Iris C. M. Pelsma, MD, MSc, of Leiden University Medical Center in The Netherlands, point out that one of the long-term complications of acromegaly is acromegalic arthropathy, which...